Asian Phytoceuticals Public Company Limited

SET:APCO Stock Report

Market Cap: ฿1.5b

Asian Phytoceuticals Past Earnings Performance

Past criteria checks 4/6

Asian Phytoceuticals's earnings have been declining at an average annual rate of -4.3%, while the Personal Products industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 3% per year. Asian Phytoceuticals's return on equity is 10.7%, and it has net margins of 29.9%.

Key information

-4.30%

Earnings growth rate

-4.88%

EPS growth rate

Personal Products Industry Growth3.67%
Revenue growth rate-3.03%
Return on equity10.70%
Net Margin29.95%
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Asian Phytoceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SET:APCO Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 26202601130
31 Dec 25200551150
30 Sep 25196511180
30 Jun 25200501230
31 Mar 25204511220
31 Dec 24211551200
30 Sep 24227641190
30 Jun 24249811160
31 Mar 24264911170
31 Dec 232931071200
30 Sep 233031161200
30 Jun 232891061190
31 Mar 23278981190
31 Dec 22250811160
30 Sep 22238751120
30 Jun 22230731080
31 Mar 22231751060
31 Dec 21223691060
30 Sep 21228641170
30 Jun 21235621250
31 Mar 21234621250
31 Dec 20248701250
30 Sep 20239691150
30 Jun 20233671100
31 Mar 20233601130
01 Jan 20248581310
30 Sep 19291681570
30 Jun 19327781770
31 Mar 19351851920
31 Dec 18370951950
30 Sep 183781002010
30 Jun 183951072080
31 Mar 184171092230
31 Dec 174161082250
30 Sep 174121212290
30 Jun 174131232310
31 Mar 174161312260
31 Dec 164211312300
30 Sep 164431242310
30 Jun 164251122290
31 Mar 164121032270
31 Dec 154091012250
30 Sep 15380812230

Quality Earnings: APCO has high quality earnings.

Growing Profit Margin: APCO's current net profit margins (29.9%) are higher than last year (24.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: APCO's earnings have declined by 4.3% per year over the past 5 years.

Accelerating Growth: APCO's earnings growth over the past year (19.1%) exceeds its 5-year average (-4.3% per year).

Earnings vs Industry: APCO earnings growth over the past year (19.1%) exceeded the Personal Products industry 6.4%.


Return on Equity

High ROE: APCO's Return on Equity (10.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/17 22:40
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Asian Phytoceuticals Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.